Sulfasalazine-induced	sulfasalazine-induced	O	O	O	O
lupus	lupus	O	O	OTHERS	I
erythematosus	erythematosus	O	O	OTHERS	I
.	.	O	O	O	O

Pneumonitis	pneumonitis	O	O	OTHERS	I
,	,	O	O	O	O
bilateral	bilateral	O	O	O	O
pleural	pleural	O	DISEASE	OTHERS	I
effusions	effusions	O	DISEASE	OTHERS	I
,	,	O	O	O	O
echocardiographic	echocardiographic	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
tamponade	tamponade	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
positive	positive	O	O	O	O
autoantibodies	autoantibodies	O	O	O	O
developed	developed	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
43-year-old	43-year-old	O	O	O	O
man	man	O	O	O	O
,	,	O	O	O	O
who	who	O	O	O	O
was	was	O	O	O	O
receiving	receiving	O	O	O	O
long-term	long-term	O	O	O	O
sulfasalazine	sulfasalazine	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
for	for	O	O	O	O
chronic	chronic	O	O	O	O
ulcerative	ulcerative	O	O	OTHERS	I
colitis	colitis	O	O	OTHERS	I
.	.	O	O	O	O

After	after	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
sulfasalazine	sulfasalazine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
completion	completion	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
six-week	six-week	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
these	these	O	O	O	O
problems	problems	O	O	O	O
resolved	resolved	O	O	O	O
over	over	O	O	O	O
a	a	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
four	four	O	O	O	O
to	to	O	O	O	O
six	six	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
suggested	suggested	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
sulfasalazine-induced	sulfasalazine-induced	O	O	O	O
lupus	lupus	O	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
manifested	manifested	O	O	O	O
with	with	O	O	O	O
serositis	serositis	O	O	OTHERS	I
and	and	O	O	O	O
pulmonary	pulmonary	O	O	O	O
parenchymal	parenchymal	O	O	O	O
involvement	involvement	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
joint	joint	O	O	O	O
symptoms	symptoms	O	O	O	O
.	.	O	O	O	O

Physicians	physicians	O	O	O	O
who	who	O	O	O	O
use	use	O	O	O	O
sulfasalazine	sulfasalazine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
treat	treat	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
inflammatory	inflammatory	O	O	OTHERS	I
bowel	bowel	O	O	OTHERS	I
disease	disease	O	O	OTHERS	I
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
sulfasalazine-induced	sulfasalazine-induced	O	O	O	O
lupus	lupus	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
.	.	O	O	O	O

